SBTi Registry
Explore 1 matching companies with public, verified Science Based Targets commitments.
Data sourced from the Science Based Targets initiative (SBTi).
Show
20
per page| Sector | Region | Near-Term Status | Size | ||||
|---|---|---|---|---|---|---|---|
| Everest Clinical Research Corporation | Pharmaceuticals, Biotechnology and Life Sciences | Northern America | Targets set | Medium | - | May 1, 2025 | |
Near-Term Status Targets set Near-Term Classification 1.5°C Near-Term Target Year 2029 Long-Term Status - Net-Zero Status - Net-Zero Year - Sector Pharmaceuticals, Biotechnology and Life Sciences Region Northern America Organization Type Corporate Location Canada Company Size Medium Target Statement Near-Term Targets: Everest Clinical Research Corporation commits to maintain zero absolute scope 1 and 2 GHG emissions from 2019 through 2029. Everest Clinical Research Corporation also commits to reduce scope 3 GHG emissions 51.6% per USD value added by 2029 from a 2019 base ye… Stakeholders No stakeholders identified yet. | |||||||
Show
20
per pageTurn Commitments Into Impact
Thousands of companies have set public Scope 3 emissions-reduction targetsthrough SBTi, but few have the tools to deliver on them. Carbon3 gives you the infrastructure to plan, track, and execute the supply-chain decarbonization work behind your commitment, turning a public pledge into measurable progress. See how it works.